Transforming Growth Factor-Alpha Levels in the Serum and Ascites of Patients withAdv anced Epithelial Ovarian Cancer

Publisher： Karger

E-ISSN： 1423-002x|47|3|200-204

ISSN： 0378-7346

Source： Gynecologic and Obstetric Investigation, Vol.47, Iss.3, 1999-03, pp. : 200-204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic Significance of Serum Soluble CD163 Level in Patients with Epithelial Ovarian Cancer

By  

Gynecologic and Obstetric Investigation, Vol. 75, Iss. 4, 2013-04 ,pp. : 263-267

Karger

Access to resources Recommend Favorite

Role of Extended Chemotherapy in Advanced Ovarian Cancer Patients with High Posttreatment Serum CA-125 Levels

By  

Gynecologic and Obstetric Investigation, Vol. 72, Iss. 1, 2011-03 ,pp. : 50-54

Karger

Access to resources Recommend Favorite

Significance of Serum and Peritoneal Fluid Lactate Dehydrogenase Levels in Ovarian Cancer

By  

Gynecologic and Obstetric Investigation, Vol. 49, Iss. 4, 2000-05 ,pp. : 272-274

Karger

Access to resources Recommend Favorite

Impact of Epidermal Growth Factor and Transforming Growth Factor Beta-1 on the Release of Fibrinolytic Factors from Cultured Endometrial and Ovarian Endometriotic Stromal Cells

By  

Gynecologic and Obstetric Investigation, Vol. 55, Iss. 1, 2003-03 ,pp. : 7-13

Karger

Access to resources Recommend Favorite

Can Optimal Primary Cytoreduction Be Predicted in Advanced Stage Epithelial Ovarian Cancer? Role of Preoperative Serum CA-125 Level

By  

Gynecologic and Obstetric Investigation, Vol. 57, Iss. 3, 2004-04 ,pp. : 153-156

Karger

Access to resources Recommend Favorite